Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Female condom

This article was originally published in The Tan Sheet

Executive Summary

Female condom: Female Health Company expects approval in Japan for its female condom during 1998, approximately a year after original forecast. FHC's Japanese partner, Taiho Pharmaceuticals, is conducting clinical trials of the product in Japan and plans to market the condom under the Mylura Femy brand name, FHC says in a recent 10-Q filing with the SEC. There are more than 600 mil. male condom units sold in Japan, with the high number resulting for the most part from the fact that oral contraceptives have never been approved in that country. FHC also notes the South African government recently has ordered 1.5 mil. units of the female condom as part of an agreement with the UN's joint Programme on AIDS. In the U.S., the condom is sold under the trade name Reality. FHC net revenues for the three months ended Dec. 31 were $1.3 mil. compared to $605,818 in the comparable period of 1996. The firm took a net loss of $1.1 mil. compared to a loss of $1.6 mil. in the same quarter a year ago...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088153

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel